Literature DB >> 22246179

Mechanism of RNA synthesis initiation by the vesicular stomatitis virus polymerase.

Benjamin Morin1, Amal A Rahmeh, Sean P J Whelan.   

Abstract

The minimal RNA synthesis machinery of non-segmented negative-strand RNA viruses comprises a genomic RNA encased within a nucleocapsid protein (N-RNA), and associated with the RNA-dependent RNA polymerase (RdRP). The RdRP is contained within a viral large (L) protein, which associates with N-RNA through a phosphoprotein (P). Here, we define that vesicular stomatitis virus L initiates synthesis via a de-novo mechanism that does not require N or P, but depends on a high concentration of the first two nucleotides and specific template requirements. Purified L copies a template devoid of N, and P stimulates L initiation and processivity. Full processivity of the polymerase requires the template-associated N protein. This work provides new mechanistic insights into the workings of a minimal RNA synthesis machine shared by a broad group of important human, animal and plant pathogens, and defines a mechanism by which specific inhibitors of RNA synthesis function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22246179      PMCID: PMC3297992          DOI: 10.1038/emboj.2011.483

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  49 in total

Review 1.  Initiation of viral RNA-dependent RNA polymerization.

Authors:  Alberdina A van Dijk; Eugene V Makeyev; Dennis H Bamford
Journal:  J Gen Virol       Date:  2004-05       Impact factor: 3.891

2.  The structural basis for RNA specificity and Ca2+ inhibition of an RNA-dependent RNA polymerase.

Authors:  Paula S Salgado; Eugene V Makeyev; Sarah J Butcher; Dennis H Bamford; David I Stuart; Jonathan M Grimes
Journal:  Structure       Date:  2004-02       Impact factor: 5.006

3.  Initiation of RNA synthesis in vitro by vesicular stomatitis virus. Role of ATP.

Authors:  D Testa; A K Banerjee
Journal:  J Biol Chem       Date:  1979-03-25       Impact factor: 5.157

4.  Both NS and L proteins are required for in vitro RNA synthesis by vesicular stomatitis virus.

Authors:  S U Emerson; Y Yu
Journal:  J Virol       Date:  1975-06       Impact factor: 5.103

5.  Characterization of the 5' and 3' ends of viral messenger RNAs isolated from BHK21 cells infected with Germiston virus (Bunyavirus).

Authors:  M Bouloy; N Pardigon; P Vialat; S Gerbaud; M Girard
Journal:  Virology       Date:  1990-03       Impact factor: 3.616

6.  Rebinding of transcriptase components (L and NS proteins) to the nucleocapsid template of vesicular stomatitis virus.

Authors:  M G Mellon; S U Emerson
Journal:  J Virol       Date:  1978-09       Impact factor: 5.103

7.  Reconstitution studies detect a single polymerase entry site on the vesicular stomatitis virus genome.

Authors:  S U Emerson
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

8.  Assembly and transcription of synthetic vesicular stomatitis virus nucleocapsids.

Authors:  S A Moyer; S Smallwood-Kentro; A Haddad; L Prevec
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

9.  Sequential phosphorylation of the phosphoprotein of vesicular stomatitis virus by cellular and viral protein kinases is essential for transcription activation.

Authors:  S Barik; A K Banerjee
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

10.  A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription.

Authors:  S J Plotch; M Bouloy; I Ulmanen; R M Krug
Journal:  Cell       Date:  1981-03       Impact factor: 41.582

View more
  52 in total

1.  Architecture and regulation of negative-strand viral enzymatic machinery.

Authors:  Philip J Kranzusch; Sean P J Whelan
Journal:  RNA Biol       Date:  2012-07-01       Impact factor: 4.652

2.  Ebolavirus polymerase uses an unconventional genome replication mechanism.

Authors:  Laure R Deflubé; Tessa N Cressey; Adam J Hume; Judith Olejnik; Elaine Haddock; Friederike Feldmann; Hideki Ebihara; Rachel Fearns; Elke Mühlberger
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-08       Impact factor: 11.205

3.  Second-site mutations selected in transcriptional regulatory sequences compensate for engineered mutations in the vesicular stomatitis virus nucleocapsid protein.

Authors:  Djamila Harouaka; Gail W Wertz
Journal:  J Virol       Date:  2012-08-08       Impact factor: 5.103

Review 4.  Polymerases of paramyxoviruses and pneumoviruses.

Authors:  Rachel Fearns; Richard K Plemper
Journal:  Virus Res       Date:  2017-01-16       Impact factor: 3.303

Review 5.  How order and disorder within paramyxoviral nucleoproteins and phosphoproteins orchestrate the molecular interplay of transcription and replication.

Authors:  Sonia Longhi; Louis-Marie Bloyet; Stefano Gianni; Denis Gerlier
Journal:  Cell Mol Life Sci       Date:  2017-06-09       Impact factor: 9.261

6.  Critical phosphoprotein elements that regulate polymerase architecture and function in vesicular stomatitis virus.

Authors:  Amal A Rahmeh; Benjamin Morin; Andreas D Schenk; Bo Liang; Bianca S Heinrich; Vesna Brusic; Thomas Walz; Sean P J Whelan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

7.  Ebola Virus Replication Stands Out.

Authors:  Wenjie Wang; Chao Wu; Gaya K Amarasinghe; Daisy W Leung
Journal:  Trends Microbiol       Date:  2019-05-30       Impact factor: 17.079

Review 8.  Initiation and regulation of paramyxovirus transcription and replication.

Authors:  Sarah L Noton; Rachel Fearns
Journal:  Virology       Date:  2015-02-13       Impact factor: 3.616

9.  Sensitivity of the polymerase of vesicular stomatitis virus to 2' substitutions in the template and nucleotide triphosphate during initiation and elongation.

Authors:  Benjamin Morin; Sean P J Whelan
Journal:  J Biol Chem       Date:  2014-02-13       Impact factor: 5.157

10.  The L-VP35 and L-L interaction domains reside in the amino terminus of the Ebola virus L protein and are potential targets for antivirals.

Authors:  Martina Trunschke; Dominik Conrad; Sven Enterlein; Judith Olejnik; Kristina Brauburger; Elke Mühlberger
Journal:  Virology       Date:  2013-04-11       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.